drugset / Trial / NCT06458400
To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain
RandomizedParallel-groupOpen-labelTreatment
Summary
This was a single-center, randomized, open-label, controlled exploratory study conducted in Chinese patients. The study planned to enroll Chinese patients to evaluate the efficacy and safety of tegileridine and oliceridine injection in the treatment of postoperative pain.
Timeline
- Start
- 2024-07-03
- Primary completion
- 2024-09-30
- Completion
- 2024-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | 1 mg | Intravenous |
| Subject | Oliceridine | Other / unclassified | 0.35 mg | Intravenous |
| Subject | Tegileridine | Small molecule | 0.05 mg | Intravenous |
Indications
No indication recorded.